These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9060620)

  • 41. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.
    Buratti E; Tisminetzky SG; D'Agaro P; Baralle FE
    J Virol; 1997 Mar; 71(3):2457-62. PubMed ID: 9032383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
    Moore JP; Sattentau QJ; Wyatt R; Sodroski J
    J Virol; 1994 Jan; 68(1):469-84. PubMed ID: 7504741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
    Poumbourios P; el Ahmar W; McPhee DA; Kemp BE
    J Virol; 1995 Feb; 69(2):1209-18. PubMed ID: 7815497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein.
    Buratti E; Tisminetzky SG; Scodeller ES; Baralle FE
    J Immunol Methods; 1996 Oct; 197(1-2):7-18. PubMed ID: 8890890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity.
    Niedrig M; Bröker M; Walter G; Stüber W; Harthus HP; Mehdi S; Gelderblom HR; Pauli G
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():951-4. PubMed ID: 1378882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5].
    Tumanova OIu; Kuvshinov VN; Orlovskaia IA; Proniaeva TR; Pokrovskiĭ AG; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2003; 37(3):556-60. PubMed ID: 12815965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
    Park EJ; Gorny MK; Zolla-Pazner S; Quinnan GV
    J Virol; 2000 May; 74(9):4183-91. PubMed ID: 10756031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
    Oldstone MB; Tishon A; Lewicki H; Dyson HJ; Feher VA; Assa-Munt N; Wright PE
    J Virol; 1991 Apr; 65(4):1727-34. PubMed ID: 2002540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.
    Shrivastava T; Samal S; Tyagi AK; Goswami S; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK
    Vaccine; 2018 Mar; 36(12):1627-1636. PubMed ID: 29429810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence.
    Wang Y; Kapoor P; Parks R; Silva-Sanchez A; Alam SM; Verkoczy L; Liao HX; Zhuang Y; Burrows P; Levinson M; Elgavish A; Cui X; Haynes BF; Schroeder H
    Immunogenetics; 2016 Feb; 68(2):145-55. PubMed ID: 26687685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
    Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
    J Virol; 2017 May; 91(9):. PubMed ID: 28202756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Competitive study of monoclonal antibodies against the HIV-1 Gp41 core structure.
    Usami O; Xiao P; Ling H; Hattori T
    Microbiol Immunol; 2006; 50(2):131-4. PubMed ID: 16490931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
    Cleveland SM; Jones TD; Dimmock NJ
    J Gen Virol; 2000 May; 81(Pt 5):1251-60. PubMed ID: 10769067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera.
    Vella C; Ferguson M; Dunn G; Meloen R; Langedijk H; Evans D; Minor PD
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2603-7. PubMed ID: 7506299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.
    Clerici M; Barassi C; Devito C; Pastori C; Piconi S; Trabattoni D; Longhi R; Hinkula J; Broliden K; Lopalco L
    AIDS; 2002 Sep; 16(13):1731-41. PubMed ID: 12218383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative alpha-helical region.
    Poumbourios P; McPhee DA; Kemp BE
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2055-62. PubMed ID: 1283526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.
    Purtscher M; Trkola A; Gruber G; Buchacher A; Predl R; Steindl F; Tauer C; Berger R; Barrett N; Jungbauer A
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1651-8. PubMed ID: 7888224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.